Pharmaron Beijing Co., Ltd. (HKG:3759)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
23.64
-0.52 (-2.15%)
Sep 9, 2025, 4:08 PM HKT
-2.15%
Market Cap58.30B
Revenue (ttm)14.37B
Net Income (ttm)1.51B
Shares Outn/a
EPS (ttm)0.86
PE Ratio38.51
Forward PE27.03
Dividend0.22 (0.93%)
Ex-Dividend DateJul 4, 2025
Volume9,422,495
Average Volume14,936,784
Open24.20
Previous Close24.16
Day's Range23.40 - 24.44
52-Week Range8.65 - 26.45
Beta0.92
RSI58.17
Earnings DateAug 22, 2025

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 21,370
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3759
Full Company Profile

Financial Performance

In 2024, Pharmaron Beijing's revenue was 12.28 billion, an increase of 6.39% compared to the previous year's 11.54 billion. Earnings were 1.79 billion, an increase of 12.01%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.